Selective reduction of c-myc mRNA in Daudi cells by human beta interferon
- PMID: 6584908
- PMCID: PMC344996
- DOI: 10.1073/pnas.81.6.1747
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon
Abstract
Under normal growth conditions, the human lymphoblastoid cell line Daudi expresses high levels of c-myc mRNA. These cells are also sensitive to growth inhibition by interferons. We have compared the levels of mRNA for the c-myc in untreated and human beta interferon (IFN-beta)-treated Daudi cells by RNA dot-blot and blot-hybridization analysis methods. Using a synthetic oligonucleotide complementary to the human c-myc mRNA as the probe, we detected a more than 75% reduction in the c-myc hybridizable poly(A)+ RNA in the IFN-beta-treated cells. This reduction in the c-myc mRNA appears to be selective because the level of actin mRNA is not significantly affected by the IFN-beta treatment. In addition, neither in vitro translation of mRNA extracted from IFN-beta-treated cells nor in vivo synthesis of cellular proteins in IFN-beta-treated cells are quantitatively affected. We surmise that the selective reduction in the amount of c-myc mRNA in IFN-beta-treated Daudi cells may be related to the IFN-induced inhibition of the Daudi tumor cell growth.
Similar articles
-
Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level.Proc Natl Acad Sci U S A. 1985 Feb;82(4):1151-4. doi: 10.1073/pnas.82.4.1151. Proc Natl Acad Sci U S A. 1985. PMID: 3856253 Free PMC article.
-
Regulation of c-myc RNA and its proteins in Daudi cells by interferon-beta.J Interferon Res. 1987 Feb;7(1):41-52. doi: 10.1089/jir.1987.7.41. J Interferon Res. 1987. PMID: 3295065
-
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells.Proc Natl Acad Sci U S A. 1985 Aug;82(15):4896-9. doi: 10.1073/pnas.82.15.4896. Proc Natl Acad Sci U S A. 1985. PMID: 3860831 Free PMC article.
-
Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha.J Biol Regul Homeost Agents. 2000 Oct-Dec;14(4):263-8. J Biol Regul Homeost Agents. 2000. PMID: 11215814 Review.
-
Interferons and oncogenes in the control of cell growth and differentiation: working hypothesis and experimental facts.Biochimie. 1988 Jul;70(7):869-75. doi: 10.1016/0300-9084(88)90227-1. Biochimie. 1988. PMID: 2462915 Review.
Cited by
-
An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1.Front Oncol. 2023 Apr 27;13:1173467. doi: 10.3389/fonc.2023.1173467. eCollection 2023. Front Oncol. 2023. PMID: 37182173 Free PMC article. Review.
-
Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro Models.Int J Mol Sci. 2019 Dec 12;20(24):6283. doi: 10.3390/ijms20246283. Int J Mol Sci. 2019. PMID: 31842516 Free PMC article.
-
Antiproliferative Properties of Type I and Type II Interferon.Pharmaceuticals (Basel). 2010 Mar 30;3(4):994-1015. doi: 10.3390/ph3040994. Pharmaceuticals (Basel). 2010. PMID: 20664817 Free PMC article.
-
Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model.J Clin Invest. 2010 Apr;120(4):1151-64. doi: 10.1172/JCI37223. Epub 2010 Mar 8. J Clin Invest. 2010. PMID: 20237412 Free PMC article.
-
Mechanisms of resistance to interferon-gamma-mediated cell growth arrest in human oral squamous carcinoma cells.J Biol Chem. 2009 Sep 11;284(37):24869-80. doi: 10.1074/jbc.M109.025932. Epub 2009 Jul 13. J Biol Chem. 2009. PMID: 19596857 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources